Acadian Asset Management’s Protara Therapeutics TARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-6,314
| Closed | -$25K | – | 1901 |
|
|
2024
Q1 | $25K | Hold |
6,314
| – | – | ﹤0.01% | 1465 |
|
|
2023
Q4 | $11K | Hold |
6,314
| – | – | ﹤0.01% | 1620 |
|
|
2023
Q3 | $10K | Hold |
6,314
| – | – | ﹤0.01% | 1592 |
|
|
2023
Q2 | $15K | Hold |
6,314
| – | – | ﹤0.01% | 1665 |
|
|
2023
Q1 | $19K | Hold |
6,314
| – | – | ﹤0.01% | 1659 |
|
|
2022
Q4 | $16K | Hold |
6,314
| – | – | ﹤0.01% | 1724 |
|
|
2022
Q3 | $18K | Hold |
6,314
| – | – | ﹤0.01% | 1608 |
|
|
2022
Q2 | $19K | Sell |
6,314
-5,416
| -46% | -$16.3K | ﹤0.01% | 1620 |
|
|
2022
Q1 | $59K | Sell |
11,730
-5,489
| -32% | -$27.6K | ﹤0.01% | 1448 |
|
|
2021
Q4 | $115K | Buy |
+17,219
| New | +$115K | ﹤0.01% | 1346 |
|
|
2018
Q4 | – | Sell |
-133
| Closed | -$10K | – | 1829 |
|
|
2018
Q3 | $10K | Hold |
133
| – | – | ﹤0.01% | 1553 |
|
|
2018
Q2 | $13K | Hold |
133
| – | – | ﹤0.01% | 1562 |
|
|
2018
Q1 | $13K | Hold |
133
| – | – | ﹤0.01% | 1531 |
|
|
2017
Q4 | $10K | Sell |
133
-42
| -24% | -$3.16K | ﹤0.01% | 1424 |
|
|
2017
Q3 | $14K | Sell |
175
-37
| -17% | -$2.96K | ﹤0.01% | 1255 |
|
|
2017
Q2 | $13K | Hold |
212
| – | – | ﹤0.01% | 1300 |
|
|
2017
Q1 | $15K | Buy |
+212
| New | +$15K | ﹤0.01% | 1404 |
|